Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.225 USD | +5.17% |
|
+5.13% | +13.71% |
May. 13 | Terns Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Terns Pharmaceuticals, Inc. Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.71% | 444M | |
+57.92% | 59.34B | |
+43.17% | 40.24B | |
-4.97% | 39.88B | |
-5.56% | 28.55B | |
+15.29% | 27.26B | |
-21.10% | 19.23B | |
+33.03% | 12.61B | |
+2.50% | 12.49B | |
+25.83% | 12.28B |
- Stock Market
- Equities
- TERN Stock
- News Terns Pharmaceuticals, Inc.
- Jefferies Adjusts Terns Pharmaceuticals Price Target to $22 From $18, Maintains Buy Rating